Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
University of Oxford
Welcome,
Profile
Billing
Logout
Products
Diseases
Products
Trials
News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
10
20
30
40
50
60
70
80
90
100
Vaxzevria
(ChAdOx1-S recombinant) / University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca
R21/Matrix-M
/ University of Oxford, Serum Institute of India
HIVconsvX
/ University of Oxford
RH5.2 VLP in Matrix-MTM
/ University of Oxford
RVF001
/ University of Oxford
VTP-800
/ Barinthus Bio, University of Oxford
vivax malaria vaccine
(ChAd63 PvDBP/MVA PvDBP) / University of Oxford
AZD2816
/ AstraZeneca, University of Oxford
ChAdOx1 biEBOV
/ University of Oxford
Pfs25-IMX313/Matrix-M1
/ University of Oxford
R78C/Matrix-M
/ University of Oxford
VTP-500
/ J&J, University of Oxford
ChAdOx1 nCov-19 intranasal
/ University of Oxford, Imperial College London
ChAdOx2 HAV
/ University of Oxford, HAV Vaccines
MVA HAV
/ University of Oxford, HAV Vaccines
MVA ME-TRAP/ChAd63 ME-TRAP
/ University of Oxford
Pfs48/45 in Matrix-M
/ University of Oxford
PvDBPII
/ University of Oxford
RH5.1/Matrix-M
/ University of Oxford
VTP-850
/ Barinthus Bio
